Dan Polen - Polen Capital Management
Holding/activity history for Xeris Biopharma Holdings, Inc. (XERS)
← All XERS superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 0 | 0.00 | Sell 100.00% | <0.01 | $5.25–8.42 · VW $6.60i | SEC | |
| 2025 Q4 | 133,416 | <0.01 | Add 0.17% | $6.47–10.08 · VW $7.84i | $1,047,316 | SEC | |
| 2025 Q3 | 133,191 | <0.01 | Add 0.15% | $4.62–8.51 · VW $6.86i | $1,084,175 | SEC | |
| 2025 Q2 | 132,994 | <0.01 | Buy | <0.01 | $3.81–5.28 · VW $4.58i | $621,082 | SEC |
Price snapshot:
Current price$8.16
52-week low$4.87
52-week high$10.08